Tinidazole
Nitroimidazole Antimicrobial — ALIMENTARY TRACT AND METABOLISM
Also known as: tindamax, tinidazol, trimonase
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Tinidazole is an ofp drug in the Nitroimidazole Antimicrobial class catalogued in DrugCentral. It was first approved by the FDA in 2004. Recorded indications include Acute amebiasis, Amebic liver abscess, Bacterial vaginosis and Giardiasis.
- Approval status: ofp (first approved 2004 by the FDA).
- Drug class: Nitroimidazole Antimicrobial.
- Indications: Acute amebiasis, Amebic liver abscess, Bacterial vaginosis, Giardiasis and Infection by Trichomonas.
- ATC code: A02BD09 (Combinations for eradication of Helicobacter pylori).
- Molecular formula: C8H13N3O4S; molecular weight 247.27 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (5)
- Acute amebiasis
- Amebic liver abscess
- Bacterial vaginosis
- Giardiasis
- Infection by Trichomonas
Contraindications (4)
- Breastfeeding (mother)
- Epilepsy
- Neutropenic disorder
- Peripheral nerve disease
Mechanism & targets
| Established pharmacologic class | Nitroimidazole Antimicrobial |
|---|
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2004-05-17 | FDA | — | MISSION PHARMA | Yes |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A02BD09 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) › Combinations for eradication of Helicobacter pylori |
G01AF21 | GENITO URINARY SYSTEM AND SEX HORMONES › GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS › ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS › Imidazole derivatives |
J01RA11 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › COMBINATIONS OF ANTIBACTERIALS › Combinations of antibacterials |
J01RA13 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › COMBINATIONS OF ANTIBACTERIALS › Combinations of antibacterials |
J01RA18 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › COMBINATIONS OF ANTIBACTERIALS › Combinations of antibacterials |
J01XD02 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER ANTIBACTERIALS › Imidazole derivatives |
P01AB02 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES › Nitroimidazole derivatives |
P01AB53 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES › Nitroimidazole derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Tinidazole is on its molecule page.
| Molecular formula | C8H13N3O4S |
|---|---|
| Molecular weight | 247.27 g/mol |
| CAS number | 19387-91-8 |
| InChIKey | HJLSLZFTEKNLFI-UHFFFAOYSA-N |
| PubChem CID | 5479 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Tinidazole used for?
DrugCentral lists the following indications for Tinidazole: Acute amebiasis, Amebic liver abscess, Bacterial vaginosis, Giardiasis and Infection by Trichomonas.
When was Tinidazole first approved?
Tinidazole was first approved by the FDA in 2004.
What drug class does Tinidazole belong to?
Tinidazole is in the Nitroimidazole Antimicrobial class.
What is the chemical formula of Tinidazole?
Tinidazole has the molecular formula C8H13N3O4S and a molecular weight of 247.27 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2671 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1220 — compound record and bioactivity
- PubChem CID 5479 — chemical identifiers
- DrugBank DB00911 — drug record
- FDA UNII 033KF7V46H — substance identity
- DailyMed: FDA labels for Tinidazole — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.